This is a non-core endpoint: only basic statistics are computed.
Benign neoplasm: Connective and other soft tissue of head, face and neck
CD2_BENIGN_CONNSOFT_HEADFACETRUNK_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
|
1. Apply sex-specific ruleNone |
- |
2. Check conditionsNone |
|
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpointsNone |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D21
- Name in latin
- Neoplasma benignum textus connectivi capitis/faciei
Similar endpoints
↥List of similar endpoints to
Benign neoplasm: Connective and other soft tissue of head, face and neck
based on the number of shared cases.
Similar with more cases:
- Benign neoplasm: Connective and other soft tissue of head, face and neck
- Other benign neoplasms of connective and other soft tissue
- Other benign neoplasms of connective and other soft tissue
- Benign neoplasms
- Benign neoplasms
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: script not run.
No upset table: script not run.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 636 | 344 | 292 |
| Unadjusted period prevalence (%) | 0.12 | 0.12 | 0.13 |
| Median age at first event (years) | 45.73 | 40.88 | 51.44 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 582
- Matched controls
- 5821
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D21.0
ICD-10 Finland
Benign neoplasm: Connective and other soft tissue of head, face and neck
5584.5
323.0
435
*
21501
ICD-8 Finland
Other benign neoplasm of muscular and connective tissue, Capitis (facie inclusa) et colli
+∞
113.3
105
*
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
23.4
107.0
158
91
130
Kela drug reimbursment
Malignant tumour
+∞
39.0
37
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
31.5
30
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
+∞
29.4
28
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
81.8
28.0
31
*
R22.1
ICD-10 Finland
Localized swelling, mass and lump, neck
10.2
27.3
55
59
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
27.3
26
*
PJA12
NOMESCO Finland
Sentinel node biopsy
272.0
25.9
26
*
QAE99
NOMESCO Finland
Other excision or repair surgery of skin and subcutaneous tissue in head and neck
17.3
24.8
39
24
H02AB02
ATC
dexamethasone; systemic
22.5
23.7
34
16
2150A
ICD-9 Finland
Other benign neoplasm of connective and other soft tissue, Head, face and neck[NEOPL BENIG CAPITIS, FACIEI ET COLLI,SIDEKUDOSPER]
+∞
23.1
22
*
115
Kela drug reimbursment
Breast cancer
+∞
22.0
21
*
A04AA02
ATC
granisetron; systemic, transdermal
+∞
21.0
20
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
114.1
20.7
22
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
19.9
19
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
17.8
17
*
EP1AE
NOMESCO Finland
Neck ultrasound examination
6.1
16.4
45
79
116
Kela drug reimbursment
Prostate cancer
+∞
15.7
15
*
D17.0
ICD-10 Finland
Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck
8.2
14.5
32
41
WF002
NOMESCO Finland
Radical radiotherapy
43.6
14.2
17
*
R22.0
ICD-10 Finland
Localized swelling, mass and lump, head
7.8
14.1
32
43
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
13.6
13
*
A03FA01
ATC
metoclopramide; systemic, rectal
2.9
13.3
87
334
4704
FHL
Neck tumor removal
71.4
12.6
14
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
12.5
12
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
12.5
12
*
2150X
ICD-9 Finland
Other benign neoplasm of connective and other soft tissue, Head, face and neck[NEOPL BENIG CAPITIS, FACIEI ET COLLI,TARK MÄÄRITT]
+∞
12.5
12
*
L02BA01
ATC
tamoxifen; oral
132.7
12.5
13
*
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
10.0
12.3
24
25
CBB30
NOMESCO Finland
Excision of lesion of eyelid
6.7
12.0
30
47
ZXA00
NOMESCO Finland
Right side
2.1
11.7
158
877
DAB00
NOMESCO Finland
Excision of lesion of auricle
15.9
10.9
17
11
L57.0
ICD-10 Finland
Actinic keratosis
3.6
10.6
48
143
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
111.9
10.4
11
*
C50.99
ICD-10 Finland
Breast, unspecified
+∞
10.4
10
*
L03AA13
ATC
pegfilgrastim; parenteral
+∞
10.4
10
*
C77.0
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
+∞
10.4
10
*
JN4BD
NOMESCO Finland
Extensive body CT
3.8
10.1
43
121
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
4.1
10.0
38
97
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
40.8
10.0
12
*
WX408
NOMESCO Finland
General anesthesy, balanced
2.0
9.6
138
778
QBE99
NOMESCO Finland
Other excision or repair of lesion of skin of trunk
9.3
9.6
19
21
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
101.6
9.4
10
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
101.6
9.4
10
*
HAC20
NOMESCO Finland
Total mastectomy
101.6
9.4
10
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
9.4
9
*
C44.30
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face without histology
+∞
9.4
9
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
9.4
9
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
9.4
9
*
UDQ12
NOMESCO Finland
Flexible laryngoscopy
3.6
9.4
41
119
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
3.6
9.0
39
113
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.9
8.7
51
184
HAB40
NOMESCO Finland
Wedge excision of mammary gland
20.4
8.5
12
6
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
91.3
8.4
9
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
91.3
8.4
9
*
HA1AA
NOMESCO Finland
X-ray mammography
4.4
8.4
29
68
ZZR00
NOMESCO Finland
Flap of skin
13.0
8.4
14
11
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
+∞
8.3
8
*
D11.0
ICD-10 Finland
Benign neoplasm: Parotid gland
7.2
8.3
19
27
WX402
NOMESCO Finland
General anaesthesia
2.2
8.1
84
412
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
17.5
8.1
12
7
D23.3
ICD-10 Finland
Benign neoplasm: Skin of other and unspecified parts of face
5.8
7.9
21
37
D18.0
ICD-10 Finland
Haemangioma, any site
7.1
7.8
18
26
L02BG04
ATC
letrozole; oral
7.6
7.7
17
23
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
10.2
7.6
14
14
WF004
NOMESCO Finland
Palliative radiotherapy
81.1
7.4
8
*
ELB40
NOMESCO Finland
Partial parotidectomy
9.5
7.3
14
15
C50
ICD-10 Finland
Malignant neoplasm of breast
+∞
7.3
7
*
C73.91
ICD-10 Finland
Papillary carcinoma of the thyroid gland (thyroid gland)
+∞
7.3
7
*
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
7.3
7
*
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
+∞
7.3
7
*
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
+∞
7.3
7
*
C50.31
ICD-10 Finland
Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor
+∞
7.3
7
*
NAR99
NOMESCO Finland
Other operation for tumour of spine, unspecified
+∞
7.3
7
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
7.3
7
*
C44.21
ICD-10 Finland
Basocellular carcinoma of the skin of the outer ear and the outer ear canal
+∞
7.3
7
*
C44.41
ICD-10 Finland
Basocellular carcinoma of the skin of the scalp and neck
+∞
7.3
7
*
X76
ICPC
Malignant neoplasm breast female
+∞
7.3
7
*
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
7.3
7
*
QAE00
NOMESCO Finland
Excision of loose skin or fold of skin from head and neck
20.3
7.1
10
5
D48.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other specified sites
12.2
7.1
12
10
WX302
NOMESCO Finland
Thoracal epidural anesthesy
4.7
7.0
22
48
WX002
NOMESCO Finland
Sedation and analgesia
1.9
7.0
108
623
JN4AD
NOMESCO Finland
Body CT examination
4.3
6.9
24
58
TQW99
NOMESCO Finland
Other minor procedure on skin
3.8
6.9
27
73
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
5.8
6.8
18
32
D21.2
ICD-10 Finland
Benign neoplasm: Connective and other soft tissue of lower limb, including hip
40.5
6.8
8
*
PJA10
NOMESCO Finland
Exploration of lymph nodes
40.5
6.8
8
*
L02AE02
ATC
leuprorelin; implant, parenteral
7.9
6.6
14
18
S18
ICPC
Laceration/cut
1.6
6.6
207
1478
ZX120
NOMESCO Finland
Intravenous
2.6
6.6
47
193
R23.8
ICD-10 Finland
Other and unspecified skin changes
2.1
6.5
71
358
CBA10
NOMESCO Finland
Biopsy of eyelid
14.5
6.4
10
7
KCD02
NOMESCO Finland
Transurethral resection of bladder
18.2
6.3
9
5
ENB99
NOMESCO Finland
Other excision of pharynx and adjacent structures
+∞
6.3
6
*
L01BC06
ATC
capecitabine; oral
+∞
6.3
6
*
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
+∞
6.3
6
*
8260/3-C73.9
ICD-O-3
Papillary adenocarcinoma, NOS, of thyroid gland
+∞
6.3
6
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
6.3
6
*
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
+∞
6.3
6
*
WD225
NOMESCO Finland
Demanding therapy of methastized malignancy with hormones
+∞
6.3
6
*
C44.39
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology
+∞
6.3
6
*
Y77
ICPC
Malignant neoplasm prostate
+∞
6.3
6
*
A04AD12
ATC
aprepitant; systemic
+∞
6.3
6
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
6.3
6
*
KEC00
NOMESCO Finland
Retropubic radical prostatectomy
+∞
6.3
6
*
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
3.7
6.3
25
69
NAR20
NOMESCO Finland
Complete excision of soft tissue tumour of spine, unspecified
27.0
6.2
8
*
D48.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified
5.8
6.2
16
28
D21.1
ICD-10 Finland
Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder
7.8
6.1
13
17
B01AB05
ATC
enoxaparin; parenteral
1.7
6.1
131
837
QAA25
NOMESCO Finland
Destruction of lesion of head or neck
6.8
6.1
14
21
SPAT1153
SPAT
Removal of sutures
1.6
6.0
160
1088
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
28
63
4.60
11.77
1.2
1.2
—
—
—
0
0
297
2123
1.75
10.65
7.4
5.5
1.2
1.2
mmol/l
0.31
266
1818
164
985
1.90
10.47
2.1
2.0
—
—
—
0
0
258
1837
1.68
8.94
4.4
3.7
35.9
36.2
g/l
0.46
247
1700
276
2040
1.62
8.02
3.9
3.7
—
—
—
0
0
49
214
2.40
7.12
4.6
1.6
14.8
4.1
ug/l
0.83
37
165
104
606
1.86
7.09
3.2
2.9
0.8
0.8
mmol/l
0.98
99
570
256
1902
1.58
7.03
6.4
5.2
1.2
1.2
mmol/l
0.28
240
1709
419
3540
1.54
6.05
8.4
5.1
76.4
74.9
u/l
0.33
394
3274
283
2205
1.51
6.00
7.0
3.7
10.9
11.4
umol/l
0.43
272
2076
192
1424
1.50
4.97
3.1
2.0
2.3
2.4
mmol/l
0.15
174
1207
129
891
1.56
4.60
3.6
3.7
713.6
388.7
ng/l
0.30
92
648
325
2707
1.41
4.39
5.1
4.2
6.6
6.6
mmol/l
0.01
307
2493
251
2001
1.42
4.34
2.5
2.3
78.0
76.3
nmol/l
0.37
227
1784
75
466
1.69
4.09
6.5
8.1
0.7
1.6
mmol/l
1.26
59
358
197
1523
1.43
3.97
3.3
2.7
32.3
31.3
u/l
0.06
189
1450
88
582
1.59
3.77
23.4
22.2
1.1
1.2
inr
0.51
14
91
56
332
1.75
3.62
4.5
3.7
78.3
81.0
ng/l
0.15
50
299
153
1147
1.44
3.61
2.4
2.1
2.6
2.9
mg/l
1.08
132
962
7
9
7.85
3.56
5.1
1.1
81.4
62.1
nmol/l
—
7
9
305
2576
1.35
3.50
9.6
6.3
3.8
4.2
e9/l
2.34
265
2230
26
120
2.22
3.43
2.7
3.4
—
—
—
0
0
37
199
1.91
3.28
1.6
1.3
31.8
26.0
iu/l
0.40
30
171
236
1941
1.34
3.13
1.9
1.9
94.6
94.7
pmol/l
0.00
131
996
409
3655
1.33
3.00
4.6
3.9
12.1
10.7
mm/h
1.12
386
3364
57
370
1.59
2.67
2.5
3.2
149.6
183.9
ng/l
0.27
49
344
76
528
1.50
2.64
2.1
2.3
21.5
24.1
%
1.23
62
456
31
170
1.87
2.63
2.0
1.8
—
—
—
0
0
83
588
1.47
2.62
2.0
2.2
2.4
2.4
g/l
0.57
78
548
93
674
1.44
2.61
2.0
1.8
—
—
—
0
0
533
5000
1.41
2.59
14.6
11.1
22.0
22.3
mg/l
0.06
432
3794
70
480
1.52
2.59
2.4
2.3
12.9
6.3
umol/l
0.50
59
411
91
659
1.44
2.57
2.0
2.2
14.0
14.0
umol/l
0.02
85
607
27
147
1.87
2.36
1.1
1.1
0.7
10.8
u/ml
—
5
20
177
1451
1.30
2.30
2.6
2.1
79.0
56.8
u/l
0.63
165
1345
103
784
1.37
2.20
2.4
2.1
2.4
2.4
mmol/l
0.19
91
667
18
89
2.05
2.07
1.1
1.5
—
—
—
0
0
96
733
1.36
2.02
2.9
2.5
0.7
1.1
e6/l
0.82
62
393
25
143
1.78
1.91
1.8
1.6
53.8
0.1
iu/ml
—
6
27
249
2171
1.24
1.90
3.0
2.7
104.4
104.6
ug/l
0.01
235
1997
171
1432
1.27
1.85
2.2
2.1
169.6
302.6
u/l
1.13
162
1342
496
4676
1.28
1.78
5.6
4.5
1.8
1.9
mu/l
0.68
464
4289
420
3891
1.23
1.74
4.7
3.8
14.8
14.7
pmol/l
0.53
397
3549
5
13
3.87
1.72
1.4
1.3
—
—
—
0
0
5
13
3.87
1.72
1.4
1.3
—
—
—
0
0
51
361
1.45
1.67
3.1
1.9
78.0
70.3
ml/min/173m2
0.78
23
147
6
19
3.18
1.66
4.8
1.3
12.6
15.6
ug/l
—
6
19
5
14
3.59
1.62
1.4
1.3
—
—
—
0
0
5
14
3.59
1.62
1.4
1.3
—
—
—
0
0
26
159
1.66
1.61
1.9
1.6
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
19
107
1.80
1.56
3.7
3.0
0.3
0.4
u/ml
0.59
12
59
0
42
0.00
1.53
0.0
1.9
—
7.4
—
0
23
145
1219
1.25
1.50
3.3
2.7
0.4
0.4
e6/l
0.08
111
898
87
687
1.31
1.49
3.0
2.7
2.4
2.9
e6/l
0.27
53
350
55
405
1.39
1.48
1.9
1.9
40.5
36.3
u/l
0.21
50
337
25
156
1.63
1.46
1.3
1.3
—
—
—
0
0
11
52
2.14
1.45
2.0
1.5
0.4
0.4
nmol/l
0.03
11
47
11
52
2.14
1.45
1.1
1.1
—
—
—
0
0
83
654
1.31
1.45
1.7
1.8
29.7
29.6
s
0.07
78
631
12
59
2.05
1.44
1.2
1.3
0.6
0.6
nmol/l
0.10
12
53
40
279
1.46
1.44
1.4
1.6
—
—
—
0
0
6
22
2.74
1.43
1.2
1.4
—
—
—
0
0
25
158
1.61
1.39
1.5
1.8
47.2
41.2
nmol/l
0.24
25
151
115
951
1.26
1.38
1.7
1.5
—
—
—
0
0
26
167
1.58
1.36
1.4
2.2
—
—
—
0
0
40
283
1.44
1.35
3.1
3.8
2.2
1.7
mmol/l
0.47
35
207
184
1603
1.21
1.35
3.4
2.9
—
—
—
0
0
49
365
1.37
1.26
1.2
1.2
102.2
136.8
iu/ml
0.26
16
152
61
471
1.33
1.24
1.9
1.8
—
—
—
0
0
11
56
1.98
1.22
1.0
1.2
—
—
—
0
0
5
19
2.64
1.22
1.4
1.3
—
—
—
0
0
5
19
2.64
1.22
1.4
1.3
—
—
—
0
0
5
19
2.64
1.22
1.4
1.3
—
—
—
0
0
5
19
2.64
1.22
1.4
1.3
—
—
—
0
0
135
1158
1.21
1.16
1.4
1.3
2.8
2.2
u/ml
0.19
38
319
60
469
1.31
1.14
1.9
1.7
—
—
—
0
0
8
40
2.01
1.12
1.0
1.1
—
—
—
0
0
555
5376
1.25
1.12
11.4
8.2
25.3
26.1
u/l
0.57
540
5160
24
160
1.52
1.11
2.4
4.2
1.8
1.4
mmol/l
0.45
24
155
8
41
1.96
1.09
1.1
1.1
—
—
—
0
0
99
829
1.23
1.08
3.1
2.5
0.8
0.8
ug/l
0.17
66
521
9
46
1.97
1.04
1.3
1.4
—
—
—
0
0
7
34
2.07
1.03
1.0
1.1
—
—
—
0
0
10
53
1.90
1.01
1.5
1.3
57.4
58.3
%
—
5
40
16
99
1.63
1.00
1.3
1.2
—
—
—
0
0
24
164
1.48
1.00
1.0
1.2
—
—
—
0
0
146
1279
1.18
1.00
2.7
2.9
1504.1
1227.9
ng/l
0.36
127
1070
7
35
2.01
1.00
1.3
1.2
—
—
—
0
0
7
35
2.01
1.00
1.3
1.2
—
—
—
0
0
7
35
2.01
1.00
1.3
1.2
—
—
—
0
0
533
5157
1.21
0.98
17.0
12.9
4.0
4.0
mmol/l
0.37
519
4987
359
3374
1.15
0.96
3.1
3.2
—
—
—
0
0
13
77
1.70
0.95
1.1
1.5
7.4
7.0
mmol/l
—
6
52
39
295
1.34
0.95
1.4
1.3
—
—
—
0
0
15
93
1.63
0.94
1.2
1.3
266.3
200.1
u/ml
—
9
49
17
110
1.56
0.91
1.5
1.7
7690.1
9287.9
e6/l
0.19
12
80
28
203
1.40
0.88
1.3
1.2
3.2
0.8
u/ml
—
5
15
18
120
1.51
0.86
2.1
2.2
10.6
11.1
mg/l
0.13
18
110
135
1192
1.17
0.85
4.5
3.4
23.6
24.3
%
0.17
60
519
51
409
1.27
0.84
2.9
3.1
5.8
5.9
kpa
0.11
51
398
23
163
1.43
0.83
1.0
1.2
—
—
—
0
0
126
1109
1.17
0.83
1.7
1.5
20.8
21.2
nmol/l
0.11
112
959
15
97
1.56
0.82
1.2
1.2
—
—
—
0
0
173
1907
0.87
0.81
3.6
3.4
—
—
—
0
0
136
1208
1.16
0.80
2.1
2.4
3997.6
5723.0
umol/l
0.18
119
1054
99
857
1.18
0.79
1.7
1.7
1003.3
1180.2
nmol/l
1.58
80
644
101
876
1.18
0.79
1.2
1.3
13.8
10.5
u/ml
0.13
46
336
6
33
1.83
0.79
1.0
1.5
—
—
—
0
0
0
26
0.00
0.78
0.0
1.0
—
—
—
0
0
50
406
1.25
0.76
2.9
3.1
1.9
2.4
mmol/l
0.48
44
322
7
38
1.85
0.73
4.4
3.4
—
—
—
0
0
15
100
1.51
0.73
1.1
1.3
—
—
—
0
0
172
1564
1.14
0.73
3.4
3.2
8.0
7.8
mmol/l
0.13
146
1323
5
25
2.01
0.73
1.0
1.1
—
—
—
0
0
7
40
1.76
0.71
1.1
1.1
—
94.4
—
0
5
7
40
1.76
0.71
1.4
1.5
—
—
—
0
0
164
1489
1.14
0.71
4.9
3.6
2.0
2.0
ug/l
0.08
148
1318
5
26
1.93
0.70
1.8
1.1
59046.0
284018.3
e6/l
—
5
13
5
92
0.54
0.67
1.4
1.6
—
—
—
0
0
34
268
1.28
0.67
1.1
1.0
—
—
—
0
0
20
145
1.39
0.66
1.2
1.2
3.3
7.5
u/ml
—
5
23
528
5147
1.15
0.66
16.9
12.9
139.8
139.7
mmol/l
0.43
517
4987
47
386
1.23
0.66
2.5
1.9
—
—
—
0
0
7
44
1.60
0.65
6.0
1.8
16.5
100.1
u/ml
—
7
38
5
29
1.73
0.64
1.0
1.4
—
—
—
0
0
10
63
1.60
0.62
4.8
2.0
13.7
13.3
%
—
10
63
505
4915
1.13
0.62
4.7
4.3
5.9
5.9
mmol/l
0.17
468
4481
8
50
1.61
0.61
1.3
1.1
—
—
—
0
0
69
595
1.18
0.61
6.5
6.7
—
—
—
0
0
8
51
1.58
0.60
1.3
1.1
—
—
—
0
0
8
51
1.58
0.60
1.3
1.1
—
—
—
0
0
148
1351
1.12
0.59
3.4
2.8
208.2
112.8
e6/l
0.21
116
1032
0
22
0.00
0.59
0.0
1.5
—
—
—
0
0
14
97
1.45
0.59
1.1
1.5
—
—
—
0
0
8
53
1.52
0.58
1.3
1.1
—
—
—
0
0
8
53
1.52
0.58
1.3
1.1
—
—
—
0
0
495
4818
1.12
0.58
3.7
3.8
1.3
1.3
mmol/l
0.30
465
4424
24
185
1.31
0.57
2.8
2.2
9550.9
2983.7
u/l
—
5
77
5
86
0.58
0.56
2.6
1.5
—
—
—
0
0
11
73
1.52
0.56
1.5
1.5
—
—
—
0
0
11
73
1.52
0.56
1.4
1.4
—
—
—
0
0
17
124
1.38
0.56
1.2
1.3
—
—
—
0
0
9
61
1.48
0.54
1.0
1.4
—
—
—
0
0
10
66
1.52
0.52
1.2
1.5
—
—
—
0
0
6
40
1.50
0.51
3.8
1.6
—
—
—
0
0
13
92
1.42
0.51
1.2
1.5
—
—
—
0
0
6
41
1.47
0.50
2.0
1.3
9975.0
148316.0
e6/l
—
6
30
17
127
1.35
0.50
1.8
1.4
—
—
—
0
0
577
5684
1.16
0.49
22.4
16.4
135.5
137.0
g/l
1.94
572
5590
17
129
1.33
0.46
1.1
1.3
481.6
452.9
mg/l
0.13
17
123
511
5004
1.11
0.45
4.2
4.2
1.4
1.5
mmol/l
0.64
482
4626
119
1294
0.90
0.45
4.1
3.5
0.0
0.0
estimate
0.69
43
425
16
208
0.76
0.44
1.8
1.8
—
—
—
0
0
160
1492
1.10
0.44
4.1
4.0
6.9
9.0
mg/mmol
0.35
97
930
5
32
1.57
0.42
1.0
1.5
—
—
—
0
0
5
32
1.57
0.42
1.4
2.7
—
—
—
0
0
231
2428
0.92
0.42
3.7
3.4
0.0
0.0
estimate
0.80
41
425
8
57
1.41
0.42
1.0
1.1
—
—
—
0
0
0
16
0.00
0.41
0.0
1.2
—
331.4
—
0
9
8
59
1.36
0.41
1.0
1.1
—
—
—
0
0
513
5033
1.10
0.41
4.2
4.3
4.7
4.7
mmol/l
0.04
490
4677
324
3122
1.08
0.40
4.6
4.0
2200.2
1635.4
e6/l
—
5
49
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
521
5118
1.10
0.39
4.8
4.7
2.8
2.8
mmol/l
0.00
491
4728
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
229
2401
0.93
0.39
4.8
4.6
0.0
0.0
estimate
0.00
43
432
9
66
1.37
0.38
1.3
1.1
—
—
—
0
0
5
36
1.39
0.38
1.0
1.1
—
—
—
0
0
229
2392
0.93
0.35
3.7
3.3
0.0
0.0
estimate
0.00
43
429
97
898
1.09
0.33
1.2
1.3
23.6
33.6
iu/ml
0.92
32
284
479
4705
1.07
0.31
14.5
9.6
83.9
83.3
ml/min/173m2
0.20
395
3739
7
53
1.32
0.31
1.3
1.1
—
—
—
0
0
7
53
1.32
0.31
1.0
1.4
—
—
—
0
0
7
56
1.25
0.29
1.0
1.5
—
—
—
0
0
26
223
1.17
0.28
1.8
1.7
—
—
—
0
0
343
3345
1.06
0.26
3.0
2.8
40.9
43.0
u/l
0.26
325
3130
30
263
1.15
0.26
1.9
1.5
—
—
—
0
0
430
4221
1.06
0.25
17.5
13.0
13.8
13.5
%
1.33
423
4121
64
590
1.09
0.25
4.8
4.5
31.2
31.6
%
0.11
52
388
13
159
0.81
0.25
1.2
1.5
—
—
—
0
0
5
42
1.19
0.21
1.0
1.2
—
—
—
0
0
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
12
0.00
0.21
0.0
2.7
—
—
—
0
0
28
249
1.13
0.21
2.2
2.5
0.5
0.2
e6/l
0.60
28
241
38
345
1.11
0.20
2.7
2.6
4.5
4.6
kpa
0.05
38
332
20
174
1.15
0.20
1.5
1.4
—
—
—
0
0
11
133
0.82
0.19
1.1
1.1
—
—
—
0
0
6
52
1.16
0.19
1.0
1.1
—
—
—
0
0
16
185
0.86
0.18
1.3
1.3
386.9
239.5
miu/ml
—
7
93
7
61
1.15
0.17
1.6
1.2
—
—
—
0
0
8
71
1.13
0.16
1.0
1.4
—
—
—
0
0
20
178
1.13
0.15
1.3
1.7
—
207.5
—
0
8
9
81
1.11
0.15
1.3
1.3
—
—
—
0
0
9
81
1.11
0.15
1.3
1.3
—
—
—
0
0
467
4624
1.04
0.14
5.8
5.6
39.6
39.6
mmol/mol
0.03
437
4305
8
100
0.80
0.13
1.8
1.4
—
—
—
0
0
9
110
0.82
0.13
1.6
1.8
—
—
—
0
0
34
316
1.08
0.13
2.6
1.8
—
—
—
0
0
16
143
1.12
0.11
1.5
2.3
41.5
73.3
ug/min
—
10
88
18
163
1.11
0.11
1.8
1.4
4.1
4.0
g/l
0.08
13
112
18
163
1.11
0.11
1.8
1.4
7.1
7.5
g/l
0.52
13
119
18
163
1.11
0.11
1.8
1.4
—
—
—
0
0
11
96
1.15
0.10
4.6
3.7
59.9
57.5
%
0.27
11
96
112
1152
0.97
0.10
3.9
3.6
1.0
1.0
kg/l
0.22
11
151
6
54
1.11
0.09
1.0
1.3
—
—
—
0
0
25
267
0.93
0.08
1.2
1.5
—
—
—
0
0
5
62
0.80
0.08
1.6
1.4
—
—
—
0
0
13
117
1.11
0.08
1.1
1.2
3.6
3.8
mmol/l
0.26
13
112
65
628
1.04
0.08
1.7
1.8
1.3
1.5
%
0.72
57
558
6
71
0.84
0.07
1.0
1.1
—
—
—
0
0
21
225
0.93
0.07
1.0
1.7
3.3
3.7
mg/l
0.11
12
165
8
75
1.07
0.07
1.0
1.1
—
—
—
0
0
8
76
1.05
0.07
5.9
5.3
335.9
379.2
umol/l
—
8
66
8
77
1.04
0.07
1.1
1.2
—
—
—
0
0
471
4685
1.02
0.06
15.6
11.9
40.0
40.5
%
0.70
347
3430
133
1350
0.98
0.05
1.7
1.7
1.3
1.4
mmol/l
1.21
118
1138
49
505
0.97
0.05
1.5
1.7
—
—
—
0
0
69
700
0.98
0.02
2.4
2.2
—
—
—
0
0
22
213
1.03
0.01
2.2
2.2
0.7
0.6
%
0.60
22
207
182
1813
1.01
0.00
3.5
3.4
66.2
59.5
ng/l
0.07
120
1189
102
1014
1.01
0.00
1.7
1.7
404.8
27123065.3
pmol/l
1.29
90
848
14
145
0.96
0.00
1.1
1.4
—
—
—
0
0
14
145
0.96
0.00
1.1
1.4
—
—
—
0
0
15
145
1.04
0.00
2.7
1.6
—
—
—
0
0
15
155
0.97
0.00
1.5
1.5
—
—
—
0
0
14
144
0.97
0.00
1.1
1.4
—
—
—
0
0
14
144
0.97
0.00
1.1
1.4
—
—
—
0
0
18
177
1.02
0.00
1.2
1.4
—
—
—
0
0
33
332
0.99
0.00
1.2
1.3
—
47.3
—
0
13
42
422
0.99
0.00
3.3
2.8
—
—
—
0
0
63
632
1.00
0.00
2.5
2.0
—
—
—
0
0
105
1048
1.00
0.00
1.7
1.7
2.0
1.0
mg/l
0.40
78
789
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
9
92
0.98
0.00
1.3
1.5
—
—
—
0
0
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
113.9
—
0
7
12
120
1.00
0.00
1.4
1.6
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
17
170
1.00
0.00
2.1
1.8
—
—
—
0
0
79
790
1.00
0.00
1.5
1.4
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_CONNSOFT_HEADFACETRUNK_EXALLC – Benign neoplasm: Connective and other soft tissue of head, face and neck
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).